Sun Yat-sen University: all 1,681 studies

Page 12 of 17. Open to participants first (610), then studies with results posted, then the rest; newest registration first within each.

• The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT03851887Phase 2
• Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)Active, not recruitingNCT03847857Phase 3
• GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
• TNT to Increase the Clinical Complete Response Rate for Distal LARCActive, not recruitingNCT03840239Phase 2
• Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma PatientsCompletedNCT03839602Phase 2
• Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
• A Clinical Trial of Extraperitonealization for Prevention of Parastomal Hernia After Ileal ConduitCompletedNCT03822234Not applicable
• SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical CancerCompletedNCT03816553Phase 2
• China Red Eye StudyCompletedNCT03814863
• China Red Eye Study on Allergic ConjunctivitisStatus unknownNCT03812952
• HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCCStatus unknownNCT03812783Phase 2
• Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCCStatus unknownNCT03812770Phase 2
• Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
• Evaluation of MBL Around Implants Placed in Crestal or Subcrestal Positions: a RCTActive, not recruitingNCT03806608Not applicable
• Information, Networks and Rewards to Optimise Adherence to Diabetic ServicesCompletedNCT03804970Not applicable
• HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCCWithdrawnNCT03803254Phase 2
• Lenvatinib for Unresectable Intrahepatic CholangiocarcinomaWithdrawnNCT03801499Phase 2
• Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing SpondylitisCompletedNCT03800797Phase 4
• Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven CriteriaWithdrawnNCT03791918Phase 3
• TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCCWithdrawnNCT03782831Phase 2
• HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCCWithdrawnNCT03780634Phase 2
• HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BStatus unknownNCT03780049Phase 3
• the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular CarcinomaStatus unknownNCT03777475Not applicable
• HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCCStatus unknownNCT03775395Phase 3
• Validation of the Utility of an Artificial System for the Large-scale Screening of ScoliosisCompletedNCT03773458Not applicable
• New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary SyndromeStatus unknownNCT03773263Phase 3
• Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for ChildrenCompletedNCT03766737Not applicable
• Attention to Retinoblastoma Diagnosed in the Trauma SettingCompletedNCT03764930
• Diagnostic Efficacy of CNN in Differentiation of Visual FieldCompletedNCT03759483
• PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.CompletedNCT03755440Phase 2
• Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCCWithdrawnNCT03746249Phase 2
• Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCCWithdrawnNCT03744247Phase 3
• A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal CarcinomaStatus unknownNCT03736330Phase 2
• Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACEWithdrawnNCT03722498Phase 2
• Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT03708822Phase 2
• Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast CancerTerminatedNCT03702868
• Maintenance Treatment With S-1 in Gastric Cancer PatientsStatus unknownNCT03701373Phase 2
• Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03700476Phase 3
• Increased Risk of ADHD Among Children With Bilateral Congenital CataractsCompletedNCT03692728
• FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLMTerminatedNCT03678428Phase 3
• Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic ChemotherapyCompletedNCT03674294Phase 3
• Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerCompletedNCT03673657Phase 2
• Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal CarcinomaStatus unknownNCT03668730Phase 2
• Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial TumorStatus unknownNCT03663764Phase 2
• Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung CancerTerminatedNCT03661567Phase 2
• Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell CarcinomaCompletedNCT03660449Phase 2
• Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerCompletedNCT03659578Phase 2
• Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant ChemotherapyStatus unknownNCT03654534Phase 3
• Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular EdemaStatus unknownNCT03641144Not applicable
• Practical Pattern of Surgical Timing of Childhood Cataract in ChinaCompletedNCT03640780
• Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.Status unknownNCT03639506Not applicable
• Validation of a Universal Cataract Intelligence PlatformCompletedNCT03623971Not applicable
• Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.WithdrawnNCT03623776Phase 2
• PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03619824Phase 2
• Artificial Intelligence Screening on Patients With Primary Angle Closure GlaucomaStatus unknownNCT03611387
• Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDSStatus unknownNCT03608592Not applicable
• An Innovative Method Fluid-jet to to Remove Residual Lens FibersStatus unknownNCT03605160Not applicable
• Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPCCompletedNCT03601390
• The Visual Plasticity During Adversity and Prosperity in Infants With Congenital CataractsCompletedNCT03593824Not applicable
• TACE-HAIC vs. HAIC for Potentially Resectable HCCStatus unknownNCT03591705Not applicable
• Gut Microbes and Metabolic Group in Different PBC Patients for UDCA ResponseCompletedNCT03590886
• Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal HaemangiomaStatus unknownNCT03571282Early Phase 1
• The Impact of Interactive, Multifaceted Approach Education on Congenital CataractStatus unknownNCT03564990Not applicable
• Postoperative Pain and Discomfort After Orbital DecompressionCompletedNCT03562611Not applicable
• A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer PatientsStatus unknownNCT03543072
• A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer PatientsStatus unknownNCT03543059
• High Dose Radiotherapy for the Treatment of Rectal CancerCompletedNCT03541304
• Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma.CompletedNCT03529266Phase 2
• Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLCStatus unknownNCT03527251Phase 1
• Impact of a Printed Decision Aid on Cataract Surgery ChoiceStatus unknownNCT03525015Not applicable
• Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes MellitusCompletedNCT03522870Not applicable
• Probiotics in PBC Patients of Poor Response to UDCAStatus unknownNCT03521297Phase 2
• Natural History and Risk Factors of TAOStatus unknownNCT03515863
• Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 DiabetesCompletedNCT03509324Phase 4
• Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLMTerminatedNCT03500874Phase 3
• Validation of the Utility of Ophthalmology Intelligent Diagnostic SystemCompletedNCT03499145
• Modified Corneal EA With Middle LKP for Severe Corneal BurnStatus unknownNCT03498846Not applicable
• Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid TumorsStatus unknownNCT03494634Phase 2
• A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLMCompletedNCT03493061Phase 2
• Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLMActive, not recruitingNCT03493048Phase 2
• A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated DiarrheaTerminatedNCT03486587Phase 2
• Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker CorrelationsStatus unknownNCT03475589Phase 4
• Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan CriteriaStatus unknownNCT03469479Phase 3
• HAIC of FOLFOX vs. HAIC of OXA for Advanced HCCStatus unknownNCT03468231Phase 3
• ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGSCompletedNCT03465241
• NY-ESO-1-specific T Cell Receptor (TCR) T Cell in SarcomaCompletedNCT03462316Phase 1
• Osimertinib as First-line Therapy for Patients With Late-stage Lung CancerStatus unknownNCT03460275Phase 2
• Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN RegimenCompletedNCT03459144Not applicable
• China OLIMPICS: China Ophthalmic Learning and Improvement Initiative in Cataract Surgery TrialCompletedNCT03458442Not applicable
• Effects of Macular Buckle Versus Vitrectomy on Macular Hole and Macular Detachment in Highly Myopic EyesCompletedNCT03433547Not applicable
• Behavioral Dynamics Between Infants With Visual Loss and Healthy ControlsCompletedNCT03431207
• PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03427827Phase 3
• Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic HepatectomyStatus unknownNCT03422913Not applicable
• Nalbuphine and Flurbiprofen for Oculoplastic SurgeryCompletedNCT03422887Not applicable
• Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent MannerCompletedNCT03415503Phase 3
• Self-adherent Wrap Techniques for Orbital SurgeryCompletedNCT03415490Not applicable
• Dongguan Eye Study of Schoolchildren and Adolescents（DESSA）WithdrawnNCT03409094
• Routine Therapy Plus Moxifloxacin in Advanced Breast CancerCompletedNCT03405168Phase 2
• Association of Haptoglobin 2-2 With Postoperative DeliriumWithdrawnNCT03392480
• Protein and microRNA Markers for Early Detection of Alzheimer's DiseaseWithdrawnNCT03388242

← Sun Yat-sen University overview and focus areas